advertisement

---

Funke S 9

Showing records 1 to 9 | Display all abstracts from Funke S

72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Anders F
PLoS ONE 2017; 12: e0175451

---

72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Funke S; Perumal N
Expert review of proteomics 2017; 14: 311-334

---

72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Teister J
PLoS ONE 2017; 12: e0175451

---

72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Bell K
Expert review of proteomics 2017; 14: 311-334

---

72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Liu A; Funke S
PLoS ONE 2017; 12: e0175451

---

72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Pfeiffer N
Expert review of proteomics 2017; 14: 311-334

---

72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Grus FH
PLoS ONE 2017; 12: e0175451

---

72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Grus FH
Expert review of proteomics 2017; 14: 311-334

---

72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Thanos S; von Pein HD; Pfeiffer N; Prokosch V
PLoS ONE 2017; 12: e0175451

---